NATAP: HIV Drug Resistance Workshop June 2004 Reports

[Guest guest]

NATAP HIV & HEPATITIS REPORTS

http://www.natap.org

XIII International HIV Drug Resistance Workshop

June 8-12, 2004

Tenrife, Canary Islands, Spain

http://www.natap.org/2004/HIVDRW/hivdrw.htm

REPORTS

SUMMARY Report from the 13th International Workshop on HIV Drug Resistance -

Written by Margolis, M.D. (06/23/04)

Nevirapine Resistance After Single Dose to Prevent Mother-To-Child HIV

Transmission -

(06/29/04)

Best Genotypic Resistance Tests To Evaluate Sensitivity To Kaletra -

(06/28/04)

Isolated Report of Kaletra Resistance - Written by Margolis, M.D.

(06/24/04)

Tenofovir in salvage therapy: K65R, TAMS, Kaletra - (06/22/04)

Tenofovir & Correlates of the K65R Mutation - (06/17/04)

Reyataz and It's I50L Mutation - (06/17/04)

Reyataz Viral Response in Experienced Patients -genotypic mutation score -

(06/17/04)

Sustiva + Kaletra: no mutations developed - (06/17/04)

Predicting Response to ddI in Experienced Patients - (06/16/04)

High Rates of Viral failure/Resistance to HAART-need for new drugs -

(06/16/04)

Predicting Response to d4T - (06/16/04)

Fuzeon Resistance - (06/16/04)

Predictors of selection of K65R: tenofovir use and lack of TAMs - (06/16/04)

In vitro resistance development for a second-generation NNRTI: TMC125 -

(06/16/04)

Viral Blips May Affect CD4 Response to HAART - (06/16/04)

Replication Capacity Affects CD4 Response to HAART - (06/16/04)

Transmitted HIV Drug Resistance Persists & May Reduce Response to HAART -

(06/16/04)

Experts Differ In Interpretation of Resistance Testing Results - (06/16/04)

Pre-Existing L74V is a Risk for Virologic Non-Response and Development of

K65R in

Patients Taking Tenofovir - (06/16/04)

Risk Of Developing Resistance Mutations During Treatment Interruptions -

(06/14/04)

GigHAART Study: treatment interruption with advanced HIV - (06/14/04)

Transmitted NNRTI Drug Resistance Results in Higher Viral Loads - (06/14/04)

Tipranavir Virally Effective in Patients with Extensive PI Resistance -

(06/14/04)

Transmitted Drug Resistance Persisted for 2-6 Years; case of superinfection -

(06/11/04)

Two New Protease Inhibitors; Novel Mechanism Leading to PI Resistance -

(06/10/04)

New HIV Protease Inhibitor at 13th Intl HIV Resistance Workshop - (06/08/04)

to get off this email list reply with your email address and unsubscribe in

the Subject.